Vanguard Portfolio Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Sell
121,412
-409,602
-77% -$591K ﹤0.01% 3108
2026
Q1
$674K Buy
+531,014
New +$999K ﹤0.01% 2902

Other funds holding HCAT

Vanguard Portfolio Management's HCAT Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its Health Catalyst (HCAT) stake by 77% in Q2 2026, selling an estimated $591K and leaving 121,412 shares worth $242K. The position accounts for ﹤0.01% of the portfolio, ranked #3108.

Vanguard Portfolio Management first reported a position in HCAT in Q1 2026 and has held it in 2 quarters since. The position peaked at $674K in Q1 2026. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Vanguard Portfolio Management held 121,412 shares of Health Catalyst worth $242K as of Q2 2026.
  • Vanguard Portfolio Management sold 409,602 Health Catalyst shares in Q2 2026, an estimated $591K.
  • Health Catalyst made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #3108 holding.
  • Vanguard Portfolio Management first reported a position in Health Catalyst in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's Health Catalyst position peaked at $674K in Q1 2026.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.